BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 [PMID: 29713132 DOI: 10.3748/wjg.v24.i16.1795]
URL: https://www.wjgnet.com/1007-9327/full/v24/i16/1795.htm
Number Citing Articles
1
Mercè Brunet, Teun van Gelder, Anders Åsberg, Vincent Haufroid, Dennis A. Hesselink, Loralie Langman, Florian Lemaitre, Pierre Marquet, Christoph Seger, Maria Shipkova, Alexander Vinks, Pierre Wallemacq, Eberhard Wieland, Jean Baptiste Woillard, Markus J. Barten, Klemens Budde, Helena Colom, Maja-Theresa Dieterlen, Laure Elens, Kamisha L. Johnson-Davis, Paweł K. Kunicki, Iain MacPhee, Satohiro Masuda, Binu S. Mathew, Olga Millán, Tomoyuki Mizuno, Dirk-Jan A. R. Moes, Caroline Monchaud, Ofelia Noceti, Tomasz Pawinski, Nicolas Picard, Ron van Schaik, Claudia Sommerer, Nils Tore Vethe, Brenda de Winter, Uwe Christians, Stein Bergan. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportTherapeutic Drug Monitoring 2019; 41(3): 261 doi: 10.1097/FTD.0000000000000640
2
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot, Laurent Gatto, Vanessa Andries, Lars Vereecke, Laure Elens, Laure B. Bindels. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1Microbiome 2023; 11(1) doi: 10.1186/s40168-023-01578-y
3
Caner Süsal, Güclü Aykut, Christian Morath, Alexander Fichtner, Christian Unterrainer, Sabine Scherer, Thuong H. Tran, Arianeb Mehrabi, Martin Zeier, Burkhard Tönshoff. Relevance of donor‐specific antibody monitoring after kidney transplantation: Findings from the Collaborative Transplant Study and the Heidelberg Transplant CenterHLA 2019; 94(S2): 11 doi: 10.1111/tan.13665
4
Tawfik Khoury, Yaron Ilan. Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF TherapiesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02726
5
Huaijun Zhu, Min Wang, Xiaofu Xiong, Yao Du, Danying Li, Zhou Wang, Weihong Ge, Yizhun Zhu. Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipientsFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1045843
6
Daryl U. Nnani, Alesa Campbell, Maria Ajaimy, Omar Saeed, Snehal R. Patel, Sana Ahmed, Jay A. Graham, Ulrich P. Jorde. Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipientsTransplant Infectious Disease 2021; 23(5) doi: 10.1111/tid.13716
7
Arnaud Del Bello, Clotilde Gaible, Nathalie Longlune, Anne-Laure Hebral, Laure Esposito, Peggy Gandia, Nassim Kamar. Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ TransplantationFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.602764
8
Amedeo De Nicolò, Michele Pinon, Alice Palermiti, Antonello Nonnato, Alessandra Manca, Jacopo Mula, Silvia Catalano, Francesco Tandoi, Renato Romagnoli, Antonio D’Avolio, Pier Luigi Calvo. Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric PatientsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.750433
9
Hyunmin Ko, Hyo Kee Kim, Chris Chung, Ahram Han, Seung-Kee Min, Jongwon Ha, Sangil Min. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipientsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84868-5
10
Kayla B. Evans, Kristi J. Beermann, Hui-Jie Lee, Matt Harris, Courtney W. Frankel, Holly Berry, Hakim Azfar Ali. Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung TransplantationTransplantation Proceedings 2022; 54(8): 2270 doi: 10.1016/j.transproceed.2022.08.007
11
Maria Eduarda Soares, Gabriela Costa, Laura Guerra, Maria Clara Morais, Nayana Vaz, Liana Codes, Paulo Lisboa Bittencourt. Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver TransplantationTherapeutic Drug Monitoring 2024;  doi: 10.1097/FTD.0000000000001192
12
Yaron Ilan. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical OutcomesFrontiers in Digital Health 2020; 2 doi: 10.3389/fdgth.2020.569178
13
Françoise Smets. Pediatric Liver Transplantation2021; : 157 doi: 10.1016/B978-0-323-63671-1.00018-5
14
Teun van Gelder. A new method to calculate intra‐patient variability in tacrolimus concentrationsBritish Journal of Clinical Pharmacology 2022; 88(6): 2581 doi: 10.1111/bcp.14865
15
Marina Serper, Alexander Burdzy, Douglas E Schaubel, Richard Mason, Arpita Banerjee, David S Goldberg, Eric F Martin, Shivan J Mehta, Louise B Russell, Amanda C Cheung, Daniela P Ladner, Julia Yoshino Benavente, Michael S Wolf. Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trialBMJ Open 2023; 13(9): e075172 doi: 10.1136/bmjopen-2023-075172
16
Mercè Brunet, Marçal Pastor-Anglada. Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and PharmacodynamicsPharmaceutics 2022; 14(9): 1755 doi: 10.3390/pharmaceutics14091755
17
Ram Gelman, Marc Berg, Yaron Ilan. A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative ReviewInternational Journal of Environmental Research and Public Health 2022; 19(3): 1722 doi: 10.3390/ijerph19031722
18
SungHyo An, Sanghoon Lee, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant RecipientsJournal of Pediatric Surgery 2023; 58(10): 2054 doi: 10.1016/j.jpedsurg.2023.05.005
19
Anat Hershko-Moshe, Yaako’v Hasin, Anat Nevo-Shor, Ohad Etzion, Yaron Ilan, Soe Thiha Maung. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming ResistanceGastroHep 2022; 2022: 1 doi: 10.1155/2022/1192547
20
Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damageBiomedicine & Pharmacotherapy 2021; 143: 112228 doi: 10.1016/j.biopha.2021.112228
21
Justa Friebus-Kardash, Ejona Nela, Birte Möhlendick, Andreas Kribben, Winfried Siffert, Falko Markus Heinemann, Ute Eisenberger. Development of De Novo Donor-specific HLA Antibodies and AMR in Renal Transplant Patients Depends on CYP3A5 GenotypeTransplantation 2022; 106(5): 1031 doi: 10.1097/TP.0000000000003871
22
Yaron Ilan, Zachary Spigelman. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistanceCancer Treatment and Research Communications 2020; 25: 100240 doi: 10.1016/j.ctarc.2020.100240
23
Eyal Shemesh. Using Medication Level Variability to Predict Posttransplant RiskLiver Transplantation 2021; 27(6): 936 doi: 10.1002/lt.26012
24
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantationGastroenterología y Hepatología (English Edition) 2020; 43(1): 34 doi: 10.1016/j.gastre.2019.09.004
25
Jordana Herblum, Niki Dacouris, Michael Huang, Jeffrey Zaltzman, G. V. Ramesh Prasad, Michelle Nash, Lucy Chen. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication AdherenceCanadian Journal of Kidney Health and Disease 2021; 8: 205435812110217 doi: 10.1177/20543581211021742
26
Hyun Jeong Kim, Juhan Lee, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim. Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20636-3
27
Nuttasith Larpparisuth, Tanapon Pongnatcha, Pera Panprom, Ratchawat Promraj, Nalinee Premasathian, Attapong Vongwiwatana. High Intrapatient Variability in Tacrolimus Exposure Calculated Over a Long Period Is Associated With De Novo Donor-Specific Antibody Development and/or Late Rejection in Thai Kidney Transplant Patients Receiving Concomitant CYP3A4/5 InhibitorsTherapeutic Drug Monitoring 2021; 43(5): 624 doi: 10.1097/FTD.0000000000000850
28
Dirk R.J. Kuypers. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical OutcomeClinical Pharmacology & Therapeutics 2020; 107(2): 347 doi: 10.1002/cpt.1618
29
Assaf Potruch, Salim T. Khoury, Yaron Ilan. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugsSeizure 2020; 80: 201 doi: 10.1016/j.seizure.2020.06.032
30
Charat Thongprayoon, Panupong Hansrivijit, Karthik Kovvuru, Swetha R. Kanduri, Tarun Bathini, Aleksandra Pivovarova, Justin R. Smith, Wisit Cheungpasitporn. Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant RecipientsJournal of Clinical Medicine 2020; 9(7): 2193 doi: 10.3390/jcm9072193
31
Maria Clara Morais, Maria Eduarda Soares, Gabriela Costa, Laura Guerra, Nayana Vaz, Liana Codes, Paulo Lisboa Bittencourt. Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantationWorld Journal of Transplantation 2023; 13(5): 254-263 doi: 10.5500/wjt.v13.i5.254
32
Yaron Ilan. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic DiseasesJournal of Personalized Medicine 2022; 12(8): 1303 doi: 10.3390/jpm12081303
33
Gwendal Coste, Florian Lemaitre. The Role of Intra-Patient Variability of Tacrolimus Drug Concentrations in Solid Organ Transplantation: A Focus on Liver, Heart, Lung and PancreasPharmaceutics 2022; 14(2): 379 doi: 10.3390/pharmaceutics14020379
34
Caner Süsal, Bernd Döhler. Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation 2019; 19(10): 2805 doi: 10.1111/ajt.15346
35
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantationGastroenterología y Hepatología 2020; 43(1): 34 doi: 10.1016/j.gastrohep.2019.09.010
36
Ewa Kwiatkowska, Kazimierz Ciechanowski, Leszek Domański, Violetta Dziedziejko, Jarosław Przybyciński, Andrzej Pawlik. Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus—Their Correlations and Effects on Long-Term Renal Allograft FunctionBiomedicines 2022; 10(11): 2860 doi: 10.3390/biomedicines10112860
37
Samuel Walters, Stephanie Yerkovich, Peter M Hopkins, Trish Leisfield, Lesleigh Winks, Daniel C Chambers, Chandima Divithotawela. Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomesJHLT Open 2024; 3: 100043 doi: 10.1016/j.jhlto.2023.100043
38
Fang Chen, June-Kong Yong, Chuan Shen, Tao Zhou, Mingxuan Feng, Ping Wan, Yi Luo, Houwen Lin, Yongbing Qian, Qiang Xia. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipientsEuropean Journal of Clinical Pharmacology 2024;  doi: 10.1007/s00228-024-03663-z
39
Ariel Kenig, Yotam Kolben, Rabea Asleh, Offer Amir, Yaron Ilan. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided AlgorithmFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.695547
40
Kosuke Takano, Sayaka Kobayashi, Hidehiro Oshibuchi, Junko Tsutsui, Nano Mishima, Satoko Ito, Rumiko Kamba, Rie Akaho, Katsuji Nishimura. Association of the Stanford Integrated Psychosocial Assessment for Transplant and 1-Year Outcome of Living Kidney Transplantation in JapanJournal of the Academy of Consultation-Liaison Psychiatry 2024; 65(1): 14 doi: 10.1016/j.jaclp.2023.09.003
41
Yamei Li, Lin Yan, Yi Li, Zhengli Wan, Yangjuan Bai, Xianding Wang, Shumeng Hu, Xiaojuan Wu, Cuili Yang, Jiwen Fan, Huan Xu, Lanlan Wang, Yunying Shi. Development and validation of routine clinical laboratory data derived marker-based nomograms for the prediction of 5-year graft survival in kidney transplant recipientsAging 2021; 13(7): 9927 doi: 10.18632/aging.202748
42
Daniel N. Marco, María Queralt Salas, Gonzalo Gutiérrez-García, Inés Monge, Gisela Riu, Esther Carcelero, Joan Ramón Roma, Noemí Llobet, Jordi Arcarons, María Suárez-Lledó, Nuria Martínez, Alexandra Pedraza, Ariadna Domenech, Laura Rosiñol, Francesc Fernández-Avilés, Álvaro Urbano-Ispízua, Montserrat Rovira, Mercè Brunet, Carmen Martínez. Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant CyclophosphamidePharmaceuticals 2022; 15(12): 1529 doi: 10.3390/ph15121529
43
Rongrong Wang, Weili Wang, Kuifen Ma, Xin Duan, Fangfang Wang, Mingzhu Huang, Wei Zhang, Tingbo Liang. Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational StudyFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01252
44
Sasha Deutsch‐Link, Ethan M. Weinberg, Therese Bittermann, Mackenzie McDougal, Aniket Dhariwal, Lauren S. Jones, Robert M. Weinrieb, Arpita G. Banerjee, Senayish Addis, Marina Serper. The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver TransplantationLiver Transplantation 2021; 27(5): 652 doi: 10.1002/lt.25975
45
Steven C. Kim, David P. Foley. Donor-specific antibodies in liver transplantation: challenges in diagnosis and determining clinical impactCurrent Opinion in Organ Transplantation 2020; 25(6): 549 doi: 10.1097/MOT.0000000000000825
46
Jérôme Dumortier, Camille Besch, Lucile Moga, Audrey Coilly, Filomena Conti, Christophe Corpechot, Arnaud Del Bello, François Faitot, Claire Francoz, Marie-Noëlle Hilleret, Pauline Houssel-Debry, Caroline Jezequel, Laurence Lavayssière, Martine Neau-Cransac, Domitille Erard-Poinsot, Victor de Lédinghen, Marc Bourlière, Christophe Bureau, Nathalie Ganne-Carrié. Non-invasive diagnosis and follow-up in liver transplantationClinics and Research in Hepatology and Gastroenterology 2022; 46(1): 101774 doi: 10.1016/j.clinre.2021.101774
47
Nobuhiro Fujiyama, Shigeru Satoh, Mitsuru Saito, Kazuyuki Numakura, Takamitsu Inoue, Ryohei Yamamoto, Takuro Saito, Taketoshi Nara, Sohei Kanda, Shintaro Narita, Hideaki Kagaya, Masatomo Miura, Tomonori Habuchi. Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantationInternational Immunopharmacology 2019; 76: 105881 doi: 10.1016/j.intimp.2019.105881
48
Suwasin Udomkarnjananun, Marith I. Francke, Brenda C.M. De Winter, Midas B. Mulder, Carla C. Baan, Herold J. Metselaar, Caroline M. den Hoed, Dennis A. Hesselink. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterologyBest Practice & Research Clinical Gastroenterology 2021; : 101756 doi: 10.1016/j.bpg.2021.101756
49
Sanyam Santosh Falari, Nihar Mohapatra, Nilesh Sadashiv Patil, Bramhadatta Pattnaik, Mohit Varshney, Ashok Choudhury, Shiv K. Sarin, Viniyendra Pamecha. Incidence and predictors of alcohol relapse following living donor liver transplantation for alcohol related liver diseaseJournal of Hepato-Biliary-Pancreatic Sciences 2023; 30(8): 1015 doi: 10.1002/jhbp.1325
50
Taisa J. Kohut, Jose F. Barandiaran, Brendan J. Keating. Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular RejectionLiver Transplantation 2020; 26(10): 1337 doi: 10.1002/lt.25812
51
Marina Serper, Adwait Chafale, Alex Burdzy, Minjee Kim, Sumeet K. Asrani, Julia Yoshino Benavente, Richard Gershon, Peter P. Reese, Douglas E. Schaubel, Justin R. Boike, Maria C. Blanco, Michael S. Wolf. Cognitive function, self-management, and outcomes among liver transplant recipients: LivCog, a multicenter, prospective studyHepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000259
52
Wei Song, Qianying Lao, Jinwei Hu, Danying Li, Yao Du, Huaijun Zhu. Lower tacrolimus time in therapeutic range is associated with inferior outcomes in adult liver transplant recipientsBasic & Clinical Pharmacology & Toxicology 2023; 132(1): 51 doi: 10.1111/bcpt.13803
53
Aleixandra Mendoza Rojas, Dennis A. Hesselink, Nicole M. van Besouw, Carla C. Baan, Teun van Gelder. Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipientsExpert Review of Clinical Immunology 2019; 15(12): 1323 doi: 10.1080/1744666X.2020.1693263
54
Sasha Deutsch-Link, Robert M. Weinrieb, Lauren S. Jones, Steven F. Solga, Ethan M. Weinberg, Marina Serper. Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver TransplantationDigestive Diseases and Sciences 2020; 65(7): 2089 doi: 10.1007/s10620-019-05937-4
55
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose SelectionClinical Pharmacokinetics 2020; 59(11): 1317 doi: 10.1007/s40262-020-00923-w
56
Laura J. Wozniak, Robert S. Venick. Donor-specific antibodies following liver and intestinal transplantation: Clinical significance, pathogenesis and recommendationsInternational Reviews of Immunology 2019; 38(3): 106 doi: 10.1080/08830185.2019.1630404
57
Cristina Dopazo, Itxarone Bilbao, Sonia García, Concepción Gómez‐Gavara, Mireia Caralt, Isabel Campos‐Varela, Lluis Castells, Ernest Hidalgo, Francisco Moreso, Bruno Montoro, Ramón Charco. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantationClinical and Translational Science 2022; 15(6): 1544 doi: 10.1111/cts.13276
58
Lauren Schumacher, Abbie D. Leino, Jeong M. Park. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspectivePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(1): 103 doi: 10.1002/phar.2480
59
David Choi, Sarang Thaker, Patricia West-Thielke, Annesti Elmasri, Christine Chan. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipientsEuropean Journal of Gastroenterology & Hepatology 2021; 33(8): 1124 doi: 10.1097/MEG.0000000000002172
60
Jessica Katharine Strong, Petra Gaylard, Heather Maher, Jean Botha. Acute Cellular Rejection in Paediatric Liver Transplants: Does a Living Donor Ameliorate the Risk of Rejection in Our Patients? A Retrospective Review at Wits Donald Gordon Medical Centre, South AfricaWits Journal of Clinical Medicine 2019; 1(3) doi: 10.18772/26180197.2019.v1n3a1